US$ 20.04
glp-1 dementia Can popular diabetes and weight-loss drugs slow vascular dementia? GLP-1s and Reduced Risk of
Description
In studies published in 1993 by Michael Nauck and colleagues in Gttingen, i.v

We have learned so much from it. From Diabetes Drug to Weight-Loss Tool When exenatide reached diabetes clinics, doctors noticed something unexpected

Gynaecol Perinatol
Action of glucagon-like peptide-1 (GLP-1) in humans.

In non-clinical studies, rodent C-cell thyroid tumours were observed with some GLP-1 receptor agonists, though the relevance to humans remains uncertain
